Renal drug transporters and drug interactions

A Ivanyuk, F Livio, J Biollaz, T Buclin - Clinical pharmacokinetics, 2017 - Springer
Transporters in proximal renal tubules contribute to the disposition of numerous drugs.
Furthermore, the molecular mechanisms of tubular secretion have been progressively …

[HTML][HTML] Moxidectin and the avermectins: consanguinity but not identity

R Prichard, C Ménez, A Lespine - … Journal for Parasitology: Drugs and Drug …, 2012 - Elsevier
The avermectins and milbemycins contain a common macrocyclic lactone (ML) ring, but are
fermentation products of different organisms. The principal structural difference is that …

Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens

G Momekov, D Momekova - Biotechnology & biotechnological …, 2020 - Taylor & Francis
The broad-spectrum antiparasitic agent ivermectin has been very recently found to inhibit
SARS-CoV-2 in vitro and proposed as a candidate for drug repurposing in COVID-19. In the …

Ivermectin, a potential anticancer drug derived from an antiparasitic drug

M Tang, X Hu, Y Wang, X Yao, W Zhang, C Yu… - Pharmacological …, 2021 - Elsevier
Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for
the treatment of many parasitic diseases such as river blindness, elephantiasis and scabies …

[HTML][HTML] Disease-drug and drug-drug interaction in COVID-19: Risk and assessment

D Kumar, N Trivedi - Biomedicine & Pharmacotherapy, 2021 - Elsevier
COVID-19 is announced as a global pandemic in 2020. Its mortality and morbidity rate are
rapidly increasing, with limited medications. The emergent outbreak of COVID-19 prompted …

[HTML][HTML] Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor …

AC Kotze, PW Hunt, P Skuce… - International Journal for …, 2014 - Elsevier
Anthelmintic resistance has a great impact on livestock production systems worldwide, is an
emerging concern in companion animal medicine, and represents a threat to our ongoing …

[HTML][HTML] P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic …

A Lespine, C Ménez, C Bourguinat… - International Journal for …, 2012 - Elsevier
Parasitic helminths cause significant disease in animals and humans. In the absence of
alternative treatments, anthelmintics remain the principal agents for their control. Resistance …

Development of inhibitors of ATP-binding cassette drug transporters–present status and challenges

S Shukla, CP Wu, SV Ambudkar - Expert opinion on drug …, 2008 - Taylor & Francis
Background: Multi-drug resistance (MDR) of cancer cells is an obstacle to effective
chemotherapy of cancer. The ATP-binding cassette (ABC) transporters, including P …

Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway

L Jiang, P Wang, YJ Sun, YJ Wu - Journal of Experimental & Clinical …, 2019 - Springer
Background Discovery and development of novel drugs that are capable of overcoming drug
resistance in tumor cells are urgently needed clinically. In this study, we sought to explore …

Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics

C Ambrus, É Bakos, B Sarkadi, C Özvegy-Laczka… - Scientific reports, 2021 - nature.com
Transporters in the human liver play a major role in the clearance of endo-and xenobiotics.
Apical (canalicular) transporters extrude compounds to the bile, while basolateral …